ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 1 filers reported holding ADICET BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $927 | +81.4% | 677,000 | +221.8% | 0.00% | +100.0% |
| Q2 2023 | $511 | -71.9% | 210,403 | -33.4% | 0.00% | -50.0% |
| Q1 2023 | $1,819 | +583.8% | 315,800 | +963.3% | 0.00% | – |
| Q4 2022 | $266 | -100.0% | 29,700 | -76.3% | 0.00% | -100.0% |
| Q2 2022 | $1,832,000 | +453.5% | 125,500 | +197.3% | 0.00% | – |
| Q3 2021 | $331,000 | -60.6% | 42,217 | -48.3% | 0.00% | -100.0% |
| Q2 2021 | $841,000 | +219.8% | 81,700 | +306.5% | 0.00% | – |
| Q1 2021 | $263,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |